A5057248496- Substance Abuse Treatment and Outcomes
- Alcohol Consumption and Health Effects
- HIV, Drug Use, Sexual Risk
- Opioid Use Disorder Treatment
- Mental Health Treatment and Access
- Global Public Health Policies and Epidemiology
- Homelessness and Social Issues
- Schizophrenia research and treatment
- Impact of Technology on Adolescents
- HIV/AIDS Research and Interventions
- Digital Mental Health Interventions
- Gambling Behavior and Treatments
- Injury Epidemiology and Prevention
- Sexuality, Behavior, and Technology
- Emergency and Acute Care Studies
- Smoking Behavior and Cessation
- Obesity, Physical Activity, Diet
- Health and Wellbeing Research
- Health Systems, Economic Evaluations, Quality of Life
- Prenatal Substance Exposure Effects
- Behavioral Health and Interventions
- Health Policy Implementation Science
- Community Health and Development
- Healthcare Systems and Public Health
- Alcoholism and Thiamine Deficiency
World Health Organization
2016-2025
Addiction Switzerland
2017-2024
World Health Organization - Pakistan
2005-2023
Collaborative Research Group
2018
Centre for Addiction and Mental Health
2018
National Institute on Alcohol Abuse and Alcoholism
2018
National Institutes of Health
2018
Auckland University of Technology
2018
Kurihama Medical and Addiction Center
2018
Pontifícia Universidade Católica de Campinas
2018
As part of a larger study to estimate the global burden disease and injury attributable alcohol: evaluate evidence for causal impact average volume alcohol consumption pattern drinking on diseases injuries; quantify relationships identified as based published meta-analyses; separate mortality versus morbidity where possible; assess quality disease.
ABSTRACT Aim The concurrent, construct and discriminative validity of the World Health Organization's Alcohol, Smoking Substance Involvement Screening Test (ASSIST) were examined in a multi‐site international study. Participants One thousand 47 participants, recruited from drug treatment ( n = 350) primary health care (PHC) settings 697), administered battery instruments. Measurements Measures included ASSIST; Addiction Severity Index‐Lite (ASI‐Lite); Dependence Scale (SDS); MINI...
Following approval of the ICD‐11 by World Health Assembly in May 2019, Organization (WHO) member states will transition from ICD‐10 to ICD‐11, with reporting health statistics based on new system begin January 1, 2022. The WHO Department Mental and Substance Abuse publish Clinical Descriptions Diagnostic Guidelines (CDDG) for Mental, Behavioural Neurodevelopmental Disorders following ICD‐11’s approval. development CDDG over past decade, principles clinical utility global applicability, has...
Shekhar Saxena and colleagues summarize the recent WHO Mental Health Gap Action Programme (mhGAP) intervention guide that provides evidence-based management recommendations for mental, neurological, substance use (MNS) disorders.
Mental disorders often coexist with other non-communicable diseases and they share many risk factors. Dan Stein colleagues examine the evidence for an integrated approach
In 2013, the American Psychiatric Association (APA) published 5th edition of its Diagnostic and Statistical Manual Mental Disorders (DSM-5). 2019, World Health Assembly approved 11th revision International Classification Diseases (ICD-11). It has often been suggested that field would benefit from a single, unified classification mental disorders, although priorities constituencies two sponsoring organizations are quite different. During development ICD-11 DSM-5, Organization (WHO) APA made...
ABSTRACT Aims Opioid substitution treatment has been studied extensively in industrialized countries, but there are relatively few studies developing/transitional countries. The aim of this study was to examine the effectiveness opioid (OST) less resourced Design Longitudinal cohort study. Setting Purposively selected OST sites Asia (China, Indonesia, Thailand), Eastern Europe (Lithuania, Poland, Ukraine), Middle East (Iran) and Australia. Participants Seven hundred twenty‐six entrants....
ABSTRACT Aims This study evaluated the effectiveness of a brief intervention (BI) for illicit drugs (cannabis, cocaine, amphetamine‐type stimulants and opioids) linked to World Health Organization (WHO) Alcohol, Smoking Substance Involvement Screening Test (ASSIST). The ASSIST screens problem or risky use 10 psychoactive substances, producing score each substance that falls into either low‐, moderate‐ high‐risk category. Design Prospective, randomized controlled trial in which participants...
Fetal alcohol spectrum disorder (FASD) is one of the most disabling potential outcomes prenatal exposure. The population-based prevalence FASD among general population Canada was unknown. objective this study to determine elementary school students, aged 7 9 years, in Greater Toronto Area (GTA) Ontario, Canada. This screening used a cross-sectional, observational design utilizing active case ascertainment, along with retrospective collection exposure information. Data involved two phases....
Abstract Background and Aims The World Health Organization ( WHO ), a growing number of other organizations, have adopted the G rading R ecommendations, A ssessment, D evelopment E valuation GRADE ) system in order to both assess quality research evidence develop clinical practice guidelines. In 2009 published guideline on psychosocially assisted pharmacological treatment opioid dependence, based results C ochrane eviews summarized using methodology. main features this are an priori...